Patients treated with a tumor necrosis factor-α inhibitor are more likely to develop extrapulmonary tuberculosis
Sang-Oh Lee
Korean J Intern Med. 2013;28(2):159-161. Published online 2013 Feb 27 DOI: https://doi.org/10.3904/kjim.2013.28.2.159
Citations to this article as recorded by 
Factors associated with extrapulmonary tuberculosis in comparison to pulmonary tuberculosis in patients with and without HIV in Bogotá, Colombia: an observational study
Andrea Vejarano-Pombo, Sandra B. Amado-Garzón, Javier I. Lasso-Apráez, Sebastián Moreno-Mercado, Samuel Martínez-Vernaza, Yulieth García-Pardo, Santiago Carvajal-Leonel
Therapeutic Advances in Infectious Disease.2025;[Epub] CrossRef
Progress in targeted therapy for ankylosing spondylitis: A review
Jiapeng Wang, Wang Lou, Yingnan Li, Yang Jiang, Xue Jiang, Lin Yang
Medicine.2024; 103(48): e40742. CrossRef
Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols
Subash C. Gupta, Amit K. Tyagi, Priya Deshmukh-Taskar, Myriam Hinojosa, Sahdeo Prasad, Bharat B. Aggarwal
Archives of Biochemistry and Biophysics.2014; 559: 91. CrossRef